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Heparin-like saccharides play an essential role in binding to the FGF-1 and to their membrane receptors 
FGFR forming a ternary complex that is responsible of the internalization of the signal, via the dimerization of 
the intracellular regions of the receptor. In this study we report the binding affinities between five synthetic 
hexasaccharides with human FGF-1 obtained by Surface Resonance Plasmon (SPR) experiments, and compare 
with the induced mitogenic activity previously obtained. These five oligosaccharides differ in the sulphation 
pattern and in the sequence. We have previously demonstrated that all the five hexasaccharides have similar 3D 
structure of the backbone. Consequently, the differences in binding affinity should have their origin in the 
substitution pattern. Subsequently, the different capacity for induction of mitogenic activity can be, at least 
partially, explained from these binding affinities. Interestingly, one of the oligosaccharides lacking of axially 
symmetry (3) was biologically inactive wh reas the other (2) was the most active. The difference between both 
compounds is the order of the FGF binding motifs along the chain relative to the carbohydrate polarity. We can 
conclude that the directionality of the GAG chain is essential for the binding and subsequent activation. The 
relative biological activity of the compounds with regular substitution pattern can be inferred from their values 
of IC50. Remarkably, the sulphate in position 6 of D-Glucosamine was essential for the mitogenic activity but not 
for the interaction with FGF-1.  
  

































































FGF-1 is a member of the Fibroblast Growth Factor family that interacts with heparin/heparan sulphate 
(Hep/HS) polysaccharides and the membrane receptors FGFRs. The formation of a ternary complex between 
FGF, FGFR and Hep/HS is the key step for the activation of the FGF signalling pathway. This is at the origin of 
different cellular essential functions as regulation of embryonic development, homeostasis and regenerative 
processes (Bernfield M et al. 1999, Eswarakumar VP et al. 2005, Kreuger J et al. 2006). Dimerization of the 
receptors and subsequent intracellular autophosphorylation activates a mitogenic response through an enzymatic 
cascade (Mohammadi M et al. 2005, Pellegrini L et al. 2000, Schlessinger J et al. 2000).  
The helical structure of heparin, a highly sulphated form of HS, directs the sulphate groups towards 
opposite sides of its longitudinal molecular axis (Mulloy B et al. 1993). According to that, the first 
crystallographic structures of the heparin and human FGF-1 complexes (pdb code: 1amx and 2amx) 
corresponded to dimeric structures linked by a regular heparin chain in its native helical structure (DiGabriele 
AD et al. 1998). However, NMR data in solution corresponded to a 1:1 complex (pdb code: 2erm) (Canales A et 
al. 2006). Remarkably, the dimers have two alternative symmetry relationships: while for 1amx the FGF-1 
proteins are related by a centre of symmetry, in the case of 2amx, the symmetry element is a plane along the 
binding site (DiGabriele AD et al. 1998). In addition, the ternary complexes of heparin and FGF with the 
extracellular domains of the membrane receptor FGFR are assembled into two different forms (pdb codes 1fq9 
and 1e0o respectively) (Schlessinger J et al. 2000),(Pellegrini L 2001, Pell grini L et al. 2000)  
The analysis of these structures indicates that the Hep/HS binding site corresponds to a swallow depression 
on the surface of the growth factor that could be considered divided into two sub-binding sites (Digabriele AD et 
al. 1998). Consequently, as heparin does not much change its helical 3D structure upon binding, in the 
monomeric case as is the NMR complex (pdb code: 2erm)(Canales A et al. 2006) some of its sulfamate groups 
will be directed towards the solvent and will not interact with the FGF-1, as the structural studies have shown. 
In order to analyse the heparin-FGF-1 binding mode, 2, a hexasaccharide with axially non-symmetric 
sulphate groups distribution and unable to form FGF dimers was prepared (Ojeda R et al. 2002). The FGF-1 
induced mitogenic activity of hexasaccharide 2 was higher than 1 (de Paz JL et al. 2001), which corresponds to 
the regular sulphation pattern of heparin (Angulo J et al. 2004) similar to the recently isolated from natural 































































sources as hexamer (Smits N et al. 2010). This result permitted to discard the dimerization of FGF-1 through a 
chain of bound heparin as a requirement for the FGF-1 mediated bioactivity. Interestingly, 3, which presents 
similar symmetry on the sulphate groups distribution than 2, with respect to the longitudinal axis, was inactive 
(de Paz JL et al. 2005). The substitution pattern of 3 was designed to fit with the requisites proposed by 
Pellegrini to maximise the interactions and symmetry in the ternary complex as it was deduced from the analysis 
of different crystallographic structures (Pellegrini L 2001). Other synthetic oligosaccharides with diverse 
sulfation patterns prepared in our group lacking of sulphate groups in all the positions 6-O of glucosamines (4) 
or in all the 2-O of iduronates (4) were also inactive (Lucas R et al. 2003). During the revision of this manuscrip 
a paper describing the synthesis of three hexasaccharides and examining their bioaffinities profiles for was 
published (Roy S et al. 2014). 
Recently performed was an in depth analysis of the three-dimensional structure of 3 using NMR and MD in 
order to search for any structural differences that might justify the loss of activity (Munoz-Garcia JC et al. 2013). 
From this analysis it was concluded that 3 exhibits the same main structural features characteristics of heparin 
than the analogues 1 and 2, which are known to promote the interaction with FGF-1; a) a well-defined rigid 
helical backbone with four residues per turn, b) a characteristic chair 1C4 - skew boat 
2SO conformational 
equilibrium for the iduronate residues, and c) a rigid behaviour of the glycosidic linkages. This structural 
analysis allows to discard any potential difference in the three-dimensional structure that could justify the 
differences in the observed biological activity between 2 and 3 (e.g. modification of the glycosidic linkages 
geometry towards an anti disposition) (Munoz-Garcia JC et al. 2013). Consequently, the main differences in 
affinity to FGF-1 among the hexasaccharides 1-5 would be due to the capacity of each sulfonate pattern to 
interact with FGF-1 as a function of its spatial distribution along the chain. 
Results 
To investigate the ability of the five synthetic oligosaccharides, 1 – 5, to interact with human FGF-1, an 
inhibition assay was set up. The growth factor, either alone or coincubated with each of the five molecules to be 
analysed, was injected over both a heparin-functionalized sensor chip and a streptavidin sensor chip, the latter 
being used as a control surface, and the interaction was followed by Surface Plasmon Resonance (SPR) 
spectroscopy (Figure 2). Injection of 8.8 nM of FGF-1 over the heparin surface produced a binding response of 
350 response units (RU) at equilibrium whereas a response of 5 RU was observed over the streptavidin surface 
(data not shown). Analysis of the results showed that these oligosaccharides strongly differ in their ability to 































































prevent FGF-1-Hep binding (Figure 2). The inhibitory activity of 1 was characterized by an IC50 of 8.3 10
-8 M 
whereas 5 did not display binding activity in the range of concentrations tested indicating that, 2-O sulphate 
groups were essential for the interaction (Angulo J et al. 2004). In contrast, 6-O sulphate groups, that are 
involved in the biological activity (Angulo J et al. 2004), seem to be dispensable for the interaction with FGF-1, 
with an IC50  = 4.7 10
-7 M for 4. 
Next, to investigate the importance of the presentation of the sulfonate groups along the chain, the same 
assay was used with 2 and 3 since both have an asymmetric sulphate distribution. Interestingly, it was observed 
that, 2 features an IC50 = 4.6 10
-7 M, thus similar to 4, although 2 has five sulphate groups compared to six for 
the regular oligosaccharide. Finally, 3, which also displays six sulphate groups with an axially asymmetric 
distribution, has a much lower binding activity, with an IC50 = 1.6 10
-6 M. Thus, while the mitogenic activity 
previously obtained was 2 > 1 >> 3, 4, 5 (Angulo J et al. 2004), in the case of the binding affinity the order was 1 
> 2, 4 >> 3 >> 5. 
Discussion 
Assuming a fundamental role for the electrostatic interactions, and considering the structural differences 
between the hexasaccharides, the sulphation pattern should be at the origin of the differences in the strength of 
the interaction and therefore in the activity. Apparent inconsistencies between the larger IC50 values for 1 
compared with 2, measured by SPR experiments, and the induction of mitogenic activity, which is larger for 2, 
can be explained considering the assembly of the ternary complex. This is essential for the biological activity, 
and additional hidden requirements may play additional roles (Pellegrini L et al. 2000, Schlessinger J et al. 2000). 
Compounds 2 and 3 , as they have their sulfonate groups directed towards one side of the molecular axis, 
only can interact with FGF using one of their half. On the contrary, as the 3D-structures of 1, 4 and 5 have an 
axially symmetric distribution of sulfonate groups, they have the possibility to interact with two molecules of 
FGF using two opposite sides of the oligosaccharide in a sandwich like fashion, with two simultaneous binding 
events (Angulo J et al. 2004, de Paz JL et al. 2001, Lucas R et al. 2003). This observation might also explain the 
observed differences between the mitogenic activity measured by proliferation studies (Angulo J et al. 2004) and 
the relative binding strength to FGF-1, reported in this study. 
The heparin binding site of FGF-1 could be divided into two spatially contiguous sub-sites (DiGabriele AD 
et al. 1998). The first one binds a trisaccharide GlcNS – IdoA2S – GlcN6S, interacting via three negatively 































































charged sulphate moieties (Saxena K et al. 2010). Such arrangement of charged groups displays the proper 
number and orientation of sulfonate groups to establish a tight interaction with FGF-1. Recent studies have 
revealed key differences between FGF-1 and FGF-2 binding to GAG in this subsite. For the case of FGF-2 the 
trisaccharide that interacts in subsite a is the complementary one, Ido2S – GlcNS – Ido2S (Saxena K et al. 2010). 
The second sub-site interacts with a disaccharide, GlcN6S – IdoA2S. A central iduronate residue with a non-
participating sulfonate group links both motifs. Remarkably, hexasaccharides 2 and 3, display simultaneously 
these two decorations for the interaction with FGF-1 but, in reverse order if the polarity of the chain is 
considered. 
In an attempt to find a satisfactory explanation to the lack of activity of 3 with respect to 2, a molecular 
modelling docking protocol was employed to analyse the molecular interactions from a structural perspective. 
Thus, the backbone of the most representative conformation of 3, taken from 500 ns of unrestrained molecular 
dynamics trajectory (Munoz-Garcia JC et al. 2013), was manually superimposed to the most representative 
structure of the NMR complex between FGF-1 and 2 (pdb 2erm). As the distances between the three sulphate 
groups directed towards the same side of the molecule were similar, two polarities for superimposition were used, 
from the reducing to non-reducing end and its reversed alternative. We have employed as first criteria, the 
alignment of the longitudinal axis of both carbohydrates.  However, the positions of the sulfonate and sulfamate 
groups of 3 were not adequate for the complete interaction with the complementary residues of the protein. After 
that, the non-reducing end trisaccharide of 3 was manually docked into the main sub-site in the “reverse” 
orientation. In this case, the rest of the oligosaccharide did not fit in the complete binding pocket and pointed 
towards outside the complex. In addition, a steric clash was observed b tween the protein side chains and the 
GlcN – IdoA – GlcN trisulphated trisaccharide of 3 (see Suppl. Info. for description of additional modes). The 
impossibility to assemble a complex with the complete set of charged interactions between the FGF-1 and the 
hexasaccharide 3, lead us to conclude that the correct polarity of the GAG chain is essential for the interaction 
with the growth factor (FGF-1). 
We decided to perform docking calculations in order to get a deeper insight into the possible binding of 3 and 
FGF-1. We have used Glide, first using the Induced Fit Docking protocol with the standard conditions and then, 
the results were subjected to a run of Single Precision Docking. In this case, the focus was put into the three 
saccharides of the triad, leading to a displaced sequence. A remarkable superimposition of the poses for this 
region was found in the solutions (see supplementary material). 































































Interestingly, 2 (Figure 3a) has both sulphate clusters in the right disposition to interact simultaneously with 
both binding sub-sites while 3 is only capable of interacting with the sub-site a (Figure 3) (Canales A et al. 2006). 
This can explain the value of IC50 for 3, 3.5 fold larger than 2. This difference can be explained considering that 
the polarity of the glycosaminoglican chain is essential for the maximum number of interactions take place. 
While the sub-site a is interacting with 2 through the trisaccharide GlcNS – IdoS – Glc6S starting at glucosamine 
in position i, the equivalent trisaccharide that binds the main subsite in the case of 3 is shifted to the GlcN at 
position i+4. The secondary binding sub-site does not establish any interaction with 3, thus explaining the lower 
affinity measured by SPR and the absence of mitogenic activity due to the failure to assemble of higher order 
complexes needed. Therefore, the interaction between FGF-1 and 3 should be weaker than 2. This should be the 
cause why 2 and 3 showed such dramatic differences in their binding affinity and bioactivity in spite of bearing 
the same two binding motifs, but in opposite order. 
Additional information can be extracted from the comparison between the affinity experiments and biological 
activity ones. For instance, the sulphation in position 6 of glucosamine that, according to our previous biological 
results, is essential for the FGF-1 mitogenic activity (Angulo J et al. 2004), it is not for the interaction with FGF-
1. That observation might be exploited in the design of potential inhibitors of the FGF-1 mediated mitogenic 
activity that being able to interact with the FGF-1, the absence of this key group prevent the assembly of the 
ternary active complex, and the subsequent biological activity. Another important conclusion that can be 
extracted from our work is the evidence of the strong influence of the polarity of the GAG chain on the binding. 
This also can be exploited for the design of inhibitors that interacting with the FGF-1 they do with the opposite 
polarity and they will not be able to form the active ternary complex.  
In summary, we have demonstrated that the polarity of the oligosaccharide chain relative to FGF–1 is a 
critical factor for the strength of the binary interaction and further assembly of the ternary complex (Brown A et 
al. 2013). 
Materials and Methods 
Syntheses of compounds 1 - 5 have been previously described (de Paz JL et al. 2001, de Paz JL and Martin-
Lomas M 2005, Lucas R et al. 2003, Ojeda R et al. 2002). 
Size defined heparin (Hep; 6 kDa) was immobilized on a Biacore sensorchip. For that purpose, Hep was 
biotinylated at its reducing end by coincubation with 10 mM biotin/LC-hydrazine for 24 h at room temperature. 































































The mixture was then extensively dialyzed against H2O to remove unreacted biotin and freeze-dried. Two flow 
cell of a CM4 sensorchip were then functionalized with approx. 2500 resonance units (RU) of streptavidin as 
described (Crublet E et al. 2008) and biotinylated HP (5 µg/ml), in HBS-EP (10 mM HEPES, 150 mM NaCl, 3 
mM EDTA, 0.005% surfactant P20, pH 7.4) was injected across one flow cells to obtain an immobilization level 
of 50 RU. The other flow cell was left untreated and served as negative control. For binding assays, 150 µl of 
FGF-1 (8.8 nM), co incubated with a range of concentration of the different oligosaccharides, were 
simultaneously injected, at a flow rate of 50 µl/min, over the control and the HP surfaces. The formed complexes 
were washed with running buffer for 3 min and the sensorchip surfaces were regenerated with a 3 minute pulse 
of 2 M NaCl. Control sensorgrams were subtracted on line from HP sensorgrams. 
The protein data bank structures 1amx, 2amx and 2erm were used for the preliminary studies of docking 
described in this paper, performed with GLIDE (Friesner RA et al. 2004). The monomer C from the 1amx 
complex was isolated from the rest of the aggregates and used to prepare the model of the hexasaccharide 3 with 
FGF-1 by superimposition of the trisaccharide of its reducing end with the one at the non-reducing end of the 
1amx and/or 2erm complexes aligning the sulfate groups. Hydrogens atoms were added to the crystallographic 
structure when it was necessary using the Maestro protein preparation module. The corresponding hexa- and 
pentasaccharides were prepared and named consistently and using partial charges from GLYCAM (Kirschner 
KN et al. 2008), ligand preparation module was run and the structure was minimized. A grid (10 x 10 x 10 Å) 
centered in the glycosaminoglycan was constructed. We first run an Induced Fit Docking with the standard 
conditions keeping the GLYCAM charges. The resulting structures were submitted to a Single Precision 
Docking, with a 10 Å grid using GLYCAM partial charges with an electrostatic cutoff of 2.0. The minimization 
was performed using OPLS-2005 force field with a dielectric constant of 4r 
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3D, Three-dimentional; FGF, Fibroblast Growth Factor; FGFR, Fibroblast Growth Factor Receptor; Hep, 
Heparin; HS, Heparan Sulfate; MD, Molecular Dynamics; NMR; Nuclear Magnetic Resonance; RU, Response 
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Legends to Figures 
 
Figure 1. Heparin hexasaccharides analysed in this work in planar representation showing the relative 
disposition of the sulphate groups according to the 3D structure of heparin (PDB code 1hpn). 
 
Figure 2. Inhibition of the FGF-1-HEP interaction by synthetic oligosaccharides. FGF-1 (8.8 nM) was 
preincubated with a range of concentrations of the different oligosaccharides and injected for 3 min over a HEP-
activated sensor chip at 50 µL/min (see Suppl. Info.). The binding responses (in RU) were recorded as a function 
of time and corresponded to the FGF-1-HEP complexes in presence of 1 (A), 2 (B), 3 (C), 4 (D) and 5 (E). The 
oligosaccharide concentrations were (from top to bottom curves in each panel) 0, 0.0055, 0.0165, 0.15, 0.5, 1.33 
and 4 µM.  
 
Figure 3. Top, representation of the binding modes relatives to the binding subsites on FGF-1 of 2 (red) and 3 
(yellow); the non-reducing is at the left. Superimposition of the NMR structure of human FGF-1 with 
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